Vimarsana
Biggest News Aggregation in the World

Algernon News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Algernon. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Algernon Today - Breaking & Trending Today

Algernon Pharmaceuticals to Move Forward with Psychedelic Drug DMT Stroke Research Program as its Lead Asset - Vimarsana News

Algernon Pharmaceuticals to Move Forward with Psychedelic Drug DMT Stroke Research Program as its Lead Asset

VANCOUVER, British Columbia, April 01, 2024 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF), a Canadian clinical stage pharmaceutical development company, is pleased to announce that it plans to move forward with its intravenous formulation of its AP-188 (“N,N-Dimethyltryptamine” or “DMT”) stroke research program as its lead asset, after having sold its Ifenprodil research program for USD $2M cash and a 20% common share

Source: yahoo.com
University Students Attack Jewish Students Honoring the Hamas Hostages - Vimarsana News

University Students Attack Jewish Students Honoring the Hamas Hostages

 

The Power Play by The Market Herald Releases a New Interview with Algernon Pharmaceuticals Discussing Their Latest News - Vimarsana News

The Power Play by The Market Herald Releases a New Interview with Algernon Pharmaceuticals Discussing Their Latest News

VANCOUVER, BC / ACCESSWIRE / January 9, 2023 / The Power Play by The Market Herald has announced the release of a new interview with Algernon Pharmaceuticals discussing their latest news.The Power Play

Algernon Pharmaceuticals Enters into a Clinical Trial Agreement with Yale University for a DMT Phase 2 Depression Study - Vimarsana News

Algernon Pharmaceuticals Enters into a Clinical Trial Agreement with Yale University for a DMT Phase 2 Depression Study

VANCOUVER, British Columbia, Oct. 24, 2022 -- Algernon Pharmaceuticals Inc.  a clinical stage pharmaceutical development company is pleased to announce that it has entered an... | October 24, 2022

Microdose Psychedelic Insights: Microdose Announces Algernon Pharmaceuticals as Wonderland's Headline Sponsor - Vimarsana News

Microdose Psychedelic Insights: Microdose Announces Algernon Pharmaceuticals as Wonderland's Headline Sponsor

Miami, Florida--(Newsfile Corp. - September 8, 2022) - Microdose Psychedelic Insights, the leading guide to the business of psychedelics, is thrilled to announce Algernon Pharmaceuticals (CSE: AGN) (FSE: